Switching from Escitalopram 20 mg to Sertraline 100 mg
For most patients, perform a direct switch from escitalopram 20 mg to sertraline 100 mg without a washout period or tapering, starting sertraline at 50 mg for one week before increasing to 100 mg.
Switching Strategy
The direct switch approach is the most practical method when transitioning between SSRIs like escitalopram and sertraline 1, 2. Both medications are SSRIs with similar mechanisms of action, making cross-tapering or washout periods unnecessary and potentially harmful by leaving patients untreated.
Step-by-Step Protocol:
Day 1:
- Stop escitalopram 20 mg completely
- Start sertraline 50 mg once daily (morning or evening, with or without food) 3
Week 2 onwards:
- Increase sertraline to 100 mg once daily 3
- The FDA label specifies that sertraline should be initiated at 50 mg for major depressive disorder, with dose increases occurring at intervals of at least 1 week 3
Rationale for Direct Switch
A direct switch is well-tolerated between SSRIs and avoids the complexity of tapering schedules that can compromise patient compliance 4. The conservative approach with gradual tapering and washout periods is only necessary when switching to or from MAOIs (requiring 14 days) or tricyclic antidepressants 5, 3, 1.
Both escitalopram and sertraline have:
- Minimal cytochrome P450 interactions
- 24-hour elimination half-lives allowing once-daily dosing
- Low risk of drug-drug interactions when directly switched 4
Monitoring Requirements
Week 1-2: Assess for:
- Withdrawal symptoms from escitalopram (headache, dizziness, irritability, insomnia)
- New adverse effects from sertraline (nausea, diarrhea, sexual dysfunction)
- Worsening depression or suicidal ideation 6, 5
Week 4-8: Evaluate therapeutic response:
- If inadequate response at 6-8 weeks on sertraline 100 mg, consider increasing to 150-200 mg/day (maximum dose) 3
- Dose changes should occur at minimum 1-week intervals 3
Common Pitfalls to Avoid
Do not use a washout period between these two SSRIs—this leaves patients untreated and risks depressive relapse 2. Washout is only mandatory for MAOI transitions (14 days minimum) 5, 3.
Do not start sertraline at 100 mg immediately—the FDA label clearly states initiation at 50 mg for major depressive disorder, with increases after at least one week 3. Starting at higher doses increases adverse effects without improving efficacy.
Do not cross-taper (overlapping both medications)—while this approach exists, it's unnecessarily complex for SSRI-to-SSRI switches and increases the risk of serotonin syndrome, though this risk is low between these specific agents 1, 2.
Alternative Considerations
If the patient experienced significant adverse effects on escitalopram 20 mg (particularly sexual dysfunction), sertraline may offer similar tolerability as both are SSRIs 6. However, if switching due to lack of efficacy after an adequate trial (6-8 weeks at therapeutic dose), evidence suggests switching within the same SSRI class versus switching to a different class shows similar response rates of 20-70% 4, 7.
The target sertraline dose of 100 mg is appropriate as a therapeutic dose, though the dose-response relationship shows continued efficacy improvements up to 150 mg 8.